Heparin is given parenterally andunfractionated heparin (UFH) has a half-life of about one to two hours afterinfusion. The half-life of low-molecular-weight heparin (LMWH) is about four toeight hours. Heparin is obtained naturally from mucosal tissues of slaughteredmeat animals such as porcine intestines or bovine lungs or preparedsynthetically.
Statistics:
EuropeHeparin Market is estimated to account for US$ 4,085.8 Mn in terms of valueby the end of 2027.
Europe Heparin Market: Drivers
Increasing prevalence of venousthromboembolism (VTE) is expected to propel growth of Europe heparin marketover the forecast period. For instance, according to NHS Scotland’s 2018report, 75,846 people were admitted to hospital for VTE in Scotland from 2008to 2017.
Europe Heparin Market: Opportunities
Potential of LMWH in reducinglung injury is expected to offer lucrative growth opportunities for players inEurope heparin market. For instance, in April 2020, researchers from Chang GungMemorial Hospital, Taiwan, reported that LMWH reduced ventilation-induced lunginjury through hypoxia inducible factor-1α in a murine endotoxemia model.
Europe Heparin Market: Restraints
Risk of heparin inducedthrombocytopenia is expected to hinder growth of the market. Heparin-inducedthrombocytopenia (HIT) is a complication of heparin therapy. There are twotypes of HIT: type 1 and type 2. Type 1 HIT occurs within two days of heparintherapy, while type 2 is observed within 4 days to 10 days of heparin therapy.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/3960
Key Takeaways:
Europe heparin market was valuedat US$ 2,698.7 Mn in 2019 and is forecast to reach a value of US$ 4,085.8 Mn by2027 at a CAGR of 6.1% between 2020 and 2027. Increasing prevalence of venousthromboembolism (VTE) is expected to propel growth of Europe heparin marketover the forecast period
Low Molecular Weight Heparinsegment held dominant position in Europe heparin market in 2019, accounting for81.4% share in terms of value, followed by Ultra Low Molecular Weight Heparin.Increasing demand for Low Molecular Weight Heparin in reducing lung injury isexpected to drive the market growth.
Market Trends
Increasing prevalence of chronickidney disease is boosting growth of the market. For instance, according to thestudy, ‘Prevalence and deaths for chronic kidney disease in 2017, andpercentage change of age-standardized rates by location, 1990–2017’ publishedin February 2020, U.K. recorded around 5,636,676 cases of chronic kidneydisease in 2017.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/europe-heparin-market-3960
Major players in the market aresourcing active pharmaceutical ingredients from Europe. For instance, inNovember 2019, Fresenius Kabi launched preservative-free Heparin SodiumInjection, USP in 5,000 USP units per 0.5 mL in Simplist ready-to-administerprefilled syringes, in the U.S. The drug’s active pharmaceutical ingredient issourced from Europe.
Europe Heparin Market:Competitive Landscape
Major players operating in Europeheparin market include, Pfizer, Inc., Sagent Pharmaceuticals, Inc., B. BraunMelsungen AG, Baxter International Inc., GlaxoSmithKline plc, Bayer AG, AnselmPharmaceuticals, Bristol-Myers Squibb Co., Dr. Reddy’s Laboratories Ltd.,Fresenius SE & Co. KGaA, Leap Labchem Co., LEO Pharma A/S, Sanofi S.A.,Syntex S.A., Teva Pharmaceutical Industries Ltd., United Biotech (P) Ltd,Amphastar Pharmaceuticals Inc., Abbott Laboratories, Aspen Pharmacare Holdings,Laboratorios Farmaceuticos ROVI SA, and Intrapharm Laboratories.
Europe Heparin Market: KeyDevelopments
Major players in the market arefocused on adopting collaboration strategies to expand their product portfolio.For instance, in September 2019, Nichi-Iko Pharmaceutical, the parent companyof Sagent Pharmaceuticals, Inc., collaborated with Eisai Co., Ltd. for thegeneric pharmaceutical business in China.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/3960
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
